Intuitive Surgical, Inc. (NASDAQ:ISRG) had its target price upped by stock analysts at Royal Bank Of Canada from $800.00 to $950.00 in a research note issued to investors on Tuesday. The brokerage currently has a “sector perform” rating on the medical equipment provider’s stock. Royal Bank Of Canada’s price target would indicate a potential upside of 0.18% from the company’s current price.
ISRG has been the topic of several other research reports. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a research note on Monday, April 24th. Canaccord Genuity reaffirmed a “buy” rating and issued a $800.00 price target on shares of Intuitive Surgical in a research note on Friday, March 24th. Barclays PLC reaffirmed a “buy” rating and issued a $800.00 price target on shares of Intuitive Surgical in a research note on Sunday, March 26th. Wedbush raised their price target on shares of Intuitive Surgical from $835.00 to $875.00 and gave the stock an “outperform” rating in a research note on Monday, April 24th. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, July 5th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Intuitive Surgical has an average rating of “Buy” and an average target price of $878.65.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 948.09 on Tuesday. The company has a market cap of $34.93 billion, a price-to-earnings ratio of 47.79 and a beta of 0.39. Intuitive Surgical has a 52 week low of $610.71 and a 52 week high of $963.54. The stock’s 50 day moving average is $908.65 and its 200-day moving average is $772.09.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.97 by $1.12. The company had revenue of $674.20 million for the quarter, compared to the consensus estimate of $664.72 million. Intuitive Surgical had a net margin of 27.99% and a return on equity of 15.41%. The firm’s revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the firm posted $4.42 EPS. On average, equities analysts anticipate that Intuitive Surgical will post $23.62 earnings per share for the current year.
WARNING: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2017/07/18/intuitive-surgical-inc-isrg-pt-raised-to-950-00.html.
In related news, CEO Gary S. Guthart sold 18,775 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $810.33, for a total value of $15,213,945.75. Following the completion of the sale, the chief executive officer now directly owns 95,573 shares in the company, valued at approximately $77,445,669.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Salvatore Brogna sold 1,306 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $915.09, for a total transaction of $1,195,107.54. Following the completion of the sale, the executive vice president now owns 977 shares of the company’s stock, valued at $894,042.93. The disclosure for this sale can be found here. Insiders sold a total of 55,306 shares of company stock worth $46,588,332 over the last 90 days. Company insiders own 2.50% of the company’s stock.
A number of institutional investors have recently bought and sold shares of ISRG. Guardian Life Insurance Co. of America raised its stake in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the period. Acropolis Investment Management LLC purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $115,000. D. Scott Neal Inc. purchased a new stake in Intuitive Surgical during the second quarter valued at approximately $120,000. Parallel Advisors LLC raised its stake in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the period. Finally, Huntington National Bank raised its stake in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the period. 97.53% of the stock is owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.